Search Result "Dose-limiting toxicities (DLT)"
A Phase I Study of OMN54 (Aneustatâ¢) in Patients with Advanced Malignancies
Journal: Clinical Cancer Drugs
Volume: 7 Issue: 2 Year: 2020 Page: 125-132
Author(s): Karen A. Gelmon,Christian Kollmannsberger,Stephen Chia,Anna V. Tinker,Teresa Mitchell,Stephen Lam,Teresa Joshi,David Kwok,John Ostrem,Simon Sutcliffe,Daniel J. Renouf
A New Model for Determining the MTD During Phase-I Trials in Pediatric Oncology
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1660-1664
Author(s): C. Faivre,D. Barbolosi,A. Iliadis
EZN-2208 (PEG-SN38), A 40 kDa Polyethylene Glycol (PEG) Conjugate, As an Anticancer Agent: Review of Preclinical and Clinical Data
Journal: Current Bioactive Compounds
Volume: 7 Issue: 1 Year: 2011 Page: 3-7
Author(s): Hong Zhao
Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma
Journal: Current Drug Therapy
Volume: 6 Issue: 2 Year: 2011 Page: 97-99
Author(s): Roula A. Farah, Soumana C. Nasser, Racha A. Sabbagh, Pele B. Dina, Toufic A. Eid
Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer
Journal: Current Clinical Pharmacology
Volume: 6 Issue: 4 Year: 2011 Page: 274-279
Author(s): Peggy Gandia, Cecile Arellano, Quentin Chalret du Rieu, Isabelle Lochon, Mario Campone, Jean-Yves Pierga, Muriel Poublanc, Isabelle Hennebelle, Thomas Filleron, Etienne Chatelut, Jean-Pierre Delord
Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Journal: Current Drug Targets
Volume: 14 Issue: 7 Year: 2013 Page: 777-797
Author(s): Umang Swami, Sanjay Goel, Sridhar Mani
Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 44-53
Author(s): Shankar Vallabhajosula,Anastasia Nikolopoulou,Yuliya S. Jhanwar,Gurveen Kaur,Scott T. Tagawa,David M. Nanus,Neil H. Bander,Stanley J. Goldsmith
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 10 Year: 2020 Page: 811-817
Author(s): Sven Nilsson,Alexander Stein,Christian Rolfo,Anne L. Kranich,Julia Mann,Konstantinos Papadimitriou,Susann Theile,Stefanie Amberg,Carsten Bokemeyer
Scheduling of Taxanes: A Review
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 226-231
Author(s): Emma J. Woodward, Chris Twelves
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 3 Year: 2007 Page: 182-190
Author(s): William C. Olson, Warren D.W. Heston, Ayyappan K. Rajasekaran